PHVS earnings date and last-quarter result: last quarter miss, P/E -10.64. Updated 2026-07-23.
Pharvaris (PHVS) Research Hub
Pharvaris (PHVS) trades on NASDAQ, NL in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 31.54 USD (+0.41%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.64, market cap 2.40B. This hub links to the full technical, earnings and options research available for PHVS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, NL |
| Last close | 31.54 USD (+0.41%) |
| 52-week range | 27.7 USD – 43.25 USD |
| Trend regime | Range |
| 14-day RSI | 52.4 (Neutral) |
| Trailing P/E | -10.64 |
| Market cap | 2.40B |
| Dividend yield | 0.00% |
Available research for PHVS
Covered Call on PHVS: how it works, illustrative setup around the real 31.54 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PHVS: how it works, illustrative setup around the real 31.54 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PHVS: how it works, illustrative setup around the real 31.54 USD price, max profit/loss, breakeven and when to use it. Educational.
PHVS technical analysis: range, last 31.54 USD, RSI 52.4, 52w range 27.7 USD–43.25 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PHVS in?
Pharvaris (PHVS) is classified under Healthcare (Biotechnology), listed on NASDAQ, NL.
Is PHVS in an uptrend or downtrend?
As of 2026-10-26, PHVS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PHVS's trailing P/E ratio?
PHVS's trailing P/E is -10.64, with a market cap of 2.40B. See the earnings research page for full valuation detail.